Search Results 671-680 of 16744 for hashimoto
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine whether oral inosine dosed to moderately elevate serum urate (from ≤5.7 mg/dL to 7.1-8.0 mg/dL) over 2 years slows ...
Alcoholic hepatitis (AH) in its severe form is an acute condition that requires early recognition and specialized tertiary medical care. It is most likely to ...
The purpose of this study is to better understand the demands on and responses of the human body to participation in extreme events, exposure to extreme ...
About this study. This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared to placebo in participants with HCC who have ...
About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...
About this study. We are currently enrolling both healthy volunteers and people who have been diagnosed with heart failure to participate in our research ...
An expert faculty guides research in the Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition.
Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.
The purpose of this study is to establish whether therapeutic-dose parenteral anticoagulation improves outcomes (reduces intubation or mortality) by 30 days ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.